acetylglucosamine has been researched along with Disease Models, Animal in 103 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (0.97) | 18.7374 |
1990's | 10 (9.71) | 18.2507 |
2000's | 20 (19.42) | 29.6817 |
2010's | 63 (61.17) | 24.3611 |
2020's | 9 (8.74) | 2.80 |
Authors | Studies |
---|---|
Arena, P; Attanasio, S; Boffa, I; Brunetti-Pierri, N; Cuomo, P; D'Alessio, AM; De Angelis, A; Desviat, LR; Ferenbach, AT; Häberle, J; Lipshutz, GS; Makris, G; Martínez-Pizarro, A; Motta, A; Nitzahn, M; Nusco, E; Paris, D; Pravata, VM; Richard, E; Rüfenacht, V; Soria, LR; van Aalten, DMF | 1 |
Bakshi, S; Barnes, JW; Benavides, GA; Brahma, MK; Chang, SF; Chatham, JC; Curfman, S; Darley-Usmar, VM; Ha, CM; He, L; Lal, H; Paterson, AJ; Potter, LA; Rajasekaran, NS; Sun, Z; Sunny, S; Umbarkar, P; Wende, AR; Xie, M; Zhang, J; Zou, L | 1 |
Feng, D; Sheng-Dong, L; Tong, W; Zhen-Xian, D | 1 |
Popov, OS; Shebeko, SK; Zupanets, IA | 1 |
Aillerie, V; Bigot, E; Cadiet, J; Chatham, JC; Denis, M; Erraud, A; Ferron, M; Gauthier, C; Lauzier, B; Mevel, M; Persello, A; Prat, V; Rozec, B | 1 |
Arumugam, TV; Jo, DG; Lai, MKP; Park, J | 1 |
Chatham, JC; Collins, HE | 1 |
Fernandes, FF; Gonçales, RA; Pitangui, NS; Roque-Barreira, MC | 1 |
Finkielsztein, S; Huegel, J; Nuss, CA; Soslowsky, LJ | 1 |
Gao, F; Jiang, T; Jin, L; Li, C; Liu, B; Qin, X; Zheng, Q | 1 |
Asahina, M; Fujinawa, R; Hirayama, H; Kajii, Y; Suzuki, T; Tozawa, R | 1 |
Burtin, M; Dang, T; Delacour, D; Leffler, H; Magescas, J; Mayeux, A; Nilsson, UJ; Poirier, F; Sengmanivong, L; Terzi, F; Viau, A | 1 |
Beaudry, F; Bernalier-Donadille, A; Garneau, P; Garrivier, A; Gobert, AP; Harel, J; Hay, AG; Jubelin, G; Le Bihan, G; Martin, C; Sicard, JF | 1 |
Jiang, M; Li, Y; Liu, S; Paschen, W; Sheng, H; Warner, DS; Yang, W; Yu, S; Yu, Z | 1 |
Johnsen, VL; Khan, A; Klein, MS; Newell, C; Rho, JM; Shearer, J; Xu, WJ; Yee, NC | 1 |
Cao, L; Kim, G; Reece, EA; Zhao, Z | 1 |
Audhya, A; Bisnett, BJ; Boyce, M; Chhetri, A; Condon, BM; Cox, NJ; Hanna, M; Knapik, EW; Luo, PM; Meister, TR; Smith, TJ; Soderblom, EJ; Unlu, G | 1 |
Bi, Y; Chow, CY; Lowry, JB; Might, M; Owings, KG | 1 |
Chen, KT; Cole, JN; Davies, MR; Henningham, A; Lund, S; Nizet, V; Uchiyama, S; van Sorge, NM; Walker, MJ | 1 |
Chi, X; Ding, F; Wei, L; Xu, H; Yu, S | 1 |
Chen, M; Chen, YF; Gong, K; Li, R; Oparil, S; Shen, H; Xu, L; Xu, O; Yao, D; Zhang, F; Zhang, Z; Zhu, H | 1 |
Pier, GB; Zaidi, T; Zaidi, TS | 1 |
Chatterjee, A; Feng, Y; Hammes, HP; Qiu, Y; Shan, S; Wieland, T | 1 |
Barone, E; Butterfield, DA; Cassano, T; Castagnola, M; Castellani, A; Di Domenico, F; Gaetani, S; Iavarone, F; Lanzillotta, C; Perluigi, M; Sharma, N; Tramutola, A; Vincenzoni, F | 1 |
Han, B; Jiang, Z; Li, Z; Liu, W; Peng, Y; Yang, Y; Zhang, W | 1 |
Cheng, Q; Chi, X; Ding, F; Wei, L; Xu, H; Yang, Y; Yu, S; Zhou, C | 1 |
Gao, M; Hao, X; He, L; Li, Y; Ma, J; Wang, J; Wei, H; Xiao, F; Yang, J; Ye, X; Zhao, S | 1 |
Bøtker, HE; Hjortbak, MV; Jensen, RV; Jespersen, NR; Johnsen, J; Kristiansen, SB; Pryds, K; Pælestik, KB | 1 |
Brünggel, K; Damo, M; Diaceri, G; Hirosue, S; Hubbell, JA; Quaglia-Thermes, X; Raczy, MM; Wilson, DS | 1 |
Bernier, SG; Bryant, AP; Bueno, L; Currie, MG; Eutamene, H; Ge, P; Graul, C; Hannig, G; Jacobson, S; Jin, H; Kessler, MM; Kurtz, CB; Liong, E; Pezzone, MA; Reza, T; Rivers, S; Shea, C; Silos-Santiago, I; Tchernychev, B; Ustinova, EE | 1 |
Cox, EJ; Marsh, SA | 1 |
Aceves, S; Broide, DH; Cho, JY; Miller, M; Pham, A; Rosenthal, P; Sakuda, S | 1 |
Carlson, GA; Dellovade, TL; Graham, DL; Gray, AJ; Hering, H; Joyce, JA; O'Moore, J; Shearman, MS; Yu, D | 1 |
Capková, K; Danyi, I; Fišerová, A; Hříbalová, V; Malý, M; Richter, J; Vannucci, L | 1 |
Gurel, Z; Pratt, MR; Sheibani, N; Zaro, BW | 1 |
Abe, K; Deguchi, K; Deguchi, S; Ikeda, Y; Kono, S; Liu, N; Liu, W; Omote, Y; Yamashita, T; Yunoki, T | 1 |
Azuma, K; Imagawa, T; Itoh, N; Kiyose, M; Kurozumi, S; Masuda, S; Minami, S; Okamoto, Y; Osaki, T; Sato, K; Tsuka, T | 1 |
Abe, K; Deguchi, K; Hishikawa, N; Kono, S; Kurata, T; Omote, Y; Sato, K; Yamashita, T | 1 |
Cao, C; Guan, G; Huang, G; Konopka, JB; Liang, W; Naseem, S; Tao, L; Wang, H; Wang, Y | 1 |
Benetti, E; Chegaev, K; Chiazza, F; Collino, M; Cutrin, JC; Fruttero, R; Lazzarato, L; Rogazzo, M | 1 |
Abdin, MZ; Datta, A; Datta, K; Kamthan, M; Majumdar, SS; Ruhela, D; Saha, P | 1 |
Konopka, JB; Naseem, S | 1 |
Cha, MY; Cho, HJ; Cho, JW; Choi, H; Choi, YJ; Dickson, DW; Hong, HS; Jin, SM; Jung, YO; Kang, MJ; Kim, C; Kim, DK; Kim, J; Mook-Jung, I; Murray, ME; Song, HK; Yi, EC | 1 |
Abe, S; Ishijima, SA | 1 |
Cassano, T; dos Santos, M; Gaetani, S; Gatta, E; Lefebvre, T; Maccari, S; Mairesse, J; Marrocco, J; Mir, AM; Nicoletti, F | 1 |
Ding, F; Liu, X; Shen, Y; Xu, H; Yang, Y; Yu, S | 1 |
Akman, YE; Çirci, E; Öztürkmen, Y; Şükür, E; Talu, C; Tüzüner, T | 1 |
El-Agnaf, OM; Kawasaki, I; Kim, DK; Lee, HJ; Lee, SJ; Lim, HS; Shim, YH; Vaikath, NN | 1 |
Brophy, PJ; Burlingame, AL; Kim, S; Maynard, JC; Milbrandt, J; Sasaki, Y; Sherman, DL; Strickland, A | 1 |
Hebrink, DM; Jenson, PE; Kottom, TJ; Limper, AH; Ramirez-Prado, JH | 1 |
Braem, A; Kucharíková, S; Mingeot-Leclercq, MP; Siala, W; Tulkens, PM; Van Bambeke, F; Van Dijck, P; Vleugels, J | 1 |
Hao, J; He, Y; Li, D; Ma, X | 1 |
Bozkurt-Guzel, C; Lederer, JA; Pier, GB; Priebe, GP; Zaidi, TH; Zaidi, TS; Zhao, G | 1 |
Champattanachai, V; Chatham, JC; Chaudry, IH; Hu, S; Marchase, RB; Yang, S; Zou, L | 1 |
Assmann, A; Carothers, A; Demcheva, M; Fischer, TH; Hechtman, HB; Matthews, J; Muise-Helmericks, RC; Orgill, DP; Perry, S; Pietramaggiori, G; Scherer, SS; Seth, A; Valeri, RC; Vournakis, JN | 1 |
Buffone, A; Chandrasekaran, EV; Lau, JT; Locke, RD; Marathe, DD; Matta, KL; Nasirikenari, M; Neelamegham, S; Xue, J | 1 |
Guven, Z; Ozkan, FU; Ozkan, K; Ramadan, S | 1 |
Brocks, CA; Chatham, JC; Marchase, RB; Nöt, LG; Vámhidy, L | 1 |
Dunder, U; Kelo, E; Mononen, I; Valtonen, P | 1 |
Abe, K; Deguchi, K; Kawai, H; Liu, N; Lukic-Panin, V; Matsuura, T; Shang, J; Tian, F; Yamashita, T; Zhang, X | 1 |
Fišerová, A; Grobárová, V; Hulíková, K; Křivohlavá, R | 1 |
Andrade, SP; Ayres, E; Da Silva, GR; Da Silva-Cunha, A; Lima, LD; Moura, SA; Órefice, RL | 1 |
Demcheva, M; Muise-Helmericks, RC; Seth, A; Vournakis, JN | 1 |
Bronson, SK; Dennis, MD; Jefferson, LS; Kimball, SR; Schrufer, TL | 1 |
Levit, RD; Taylor, WR | 1 |
Abe, S; Cannon, RD; Hayama, K; Holmes, AR; Ishijima, SA; Takahashi, M | 1 |
Bakker, SJ; Braunagel, M; Brinkkötter, P; Deinzer, M; Hammes, HP; Henning, RH; Koeppel, H; Krämer, BK; Navis, G; Pfister, F; Riedl, E; Sternik, P; van den Born, J; Yard, B | 1 |
Clark, T; Macauley, MS; Shan, X; Skorobogatko, Y; Vocadlo, DJ; Vosseller, K; Yuzwa, SA | 1 |
Chen, H; Endo, Y; Fujita, T; Hou, W; Jeza, VT; Pan, Q; Wang, F; Xiang, T; Zhang, XL; Zhao, Y; Zhu, Y | 1 |
Azuma, K; Imagawa, T; Minami, S; Okamoto, Y; Osaki, T; Tsuka, T; Wakuda, T | 1 |
Chatham, JC; Dell'italia, LJ; Marsh, SA; Powell, PC | 1 |
Bentancor, LV; Bozkurt-Guzel, C; Cywes-Bentley, C; Maira-Litrán, T; O'Malley, JM; Pier, GB | 1 |
Forsythe, ME; Hanover, JA; Krause, MW; Lazarus, BD; Love, DC; Wang, P | 1 |
Gong, CX; Iqbal, K; Liu, F | 1 |
Buus Kristiansen, S; Bøtker, HE; Johnsen, J; Vibjerg Jensen, R; Zachara, NE | 1 |
DeMaria, TF; Grants, I; Liu, X; Tong, HH | 1 |
Akimoto, Y; Hida, T; Hirano, H; Kawakami, H; Munetomo, E; Yamamoto, K | 1 |
Ancsin, J; Bhat, S; Kisilevsky, R; Li, Z; Marone, S; Szarek, WA | 1 |
Connolly, RJ | 1 |
Bellinger, D; Chan, MW; Cole, DJ; Connolly, RJ; Nichols, T; Read, M; Schwaitzberg, SD | 1 |
Hirabayashi, K; Jensen, DM; Machicado, GA | 1 |
Favuzza, J; Hechtman, HB | 1 |
Ancsin, J; Kisilevsky, R; Li, Z; Marone, S; Szarek, WA; Vohra, R | 1 |
Ishibashi, Y; Itakura, T; Itoh, K; Kuroki, A; Kuwahara, J; Tsuji, D; Yamanaka, S | 1 |
Becker, RE; Burnett, AL; Kramer, MF; Musicki, B | 1 |
Breborowicz, A; Oreopoulos, DG; Połubinska, A; Tam, P; Wu, G | 1 |
Ashwell, G; Forsythe, ME; Hanover, JA; Kim, EJ; Krause, MW; Lazarus, BD; Love, DC; Prinz, WA | 1 |
Hascall, VC; Lauer, ME; Wang, A | 1 |
Cerca, N; Goldmann, DA; Grout, M; Jefferson, KK; Maira-Litrán, T; Pier, GB | 1 |
Alperovich, M; Chan, RK; Demcheva, M; Hechtman, HB; Kaipainen, A; Newalder, J; Orgill, DP; Pietramaggiori, G; Scherer, SS; Valeri, CR; Vournakis, JN; Yang, HJ | 1 |
Crawford, GL; Hart, GW; Whiteheart, SW | 1 |
Chatham, JC; Chen, YF; Feng, W; Majid-Hassan, E; Miller, AP; Nöt, LG; Oparil, S; Xing, D; Zhang, Y | 1 |
Sly, WS | 1 |
Gonzalez-Gomez, I; Groffen, J; Heisterkamp, N; Kaartinen, V; Mononen, I; Noronkoski, T; Voncken, JW | 1 |
Bond, A; Hay, FC; Ratkay, LG; Waterfield, JD | 1 |
Autti, T; Ginns, EI; Ikonen, S; Jalanko, A; Joensuu, R; LaMarca, ME; Manninen, T; McKinney, CE; Peltonen, L; Rapola, J; Riekkinen, P; Sipilä, I; Tenhunen, K | 1 |
Azuma, I; Hiratai, R; Ishihara, C; Nose, M; Tsuji, M; Yagi, K | 1 |
Gonzalez-Gomez, I; Groffen, J; Heisterkamp, N; Kaartinen, V; Mononen, I; Noronkoski, T | 1 |
Demcheva, MV; Finkielsztein, S; Hawes, RH; Kulling, D; Rios, G; Tagge, DU; Vournakis, JN; Woo, S | 1 |
Adams, DB; Baron, PL; Byrne, TK; Chan, MW; Cole, DJ; Connolly, RJ; Demcheva, M; Metcalf, JS; O'Brien, PH; Schwaitzberg, SD; Vournakis, J | 1 |
Aronson, NN | 1 |
Dawson, G; Huffman, PS; Jones, MZ; Thompson, JN | 1 |
Bond, A; Cooke, A; Hay, FC | 1 |
5 review(s) available for acetylglucosamine and Disease Models, Animal
Article | Year |
---|---|
O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease.
Topics: Acetylglucosamine; Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antigens, Neoplasm; Brain; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Glycosylation; Hexosamines; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Insulin Resistance; Molecular Structure; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Phosphorylation; Protein Isoforms; Protein Processing, Post-Translational; Stroke; tau Proteins; Uridine Diphosphate; Uridine Diphosphate N-Acetylgalactosamine | 2020 |
Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
Topics: Acetylglucosamine; Animals; Cardiovascular Diseases; Disease Models, Animal; Feeding Behavior; Heart; Humans; Myocardium; N-Acetylglucosaminyltransferases; Nutrients; Protein Processing, Post-Translational; Stress, Physiological | 2020 |
Liquid Poly-N-acetyl Glucosamine (sNAG) Improves Achilles Tendon Healing in a Rat Model.
Topics: Acetylglucosamine; Achilles Tendon; Animals; Biomechanical Phenomena; Disease Models, Animal; Male; Rats, Sprague-Dawley; Tendon Injuries | 2021 |
N-acetylglucosamine Regulates Virulence Properties in Microbial Pathogens.
Topics: Acetylglucosamine; Animals; Bacteria; Disease Models, Animal; Fungi; Gene Expression; Humans; Virulence | 2015 |
Aspartylglycosaminuria: biochemistry and molecular biology.
Topics: Acetylglucosamine; Amino Acid Sequence; Animals; Aspartylglucosylaminase; Base Sequence; Disease Models, Animal; DNA, Complementary; Evolution, Molecular; Finland; Gene Deletion; Gene Rearrangement; Glycoproteins; Humans; Lysosomal Storage Diseases; Lysosomes; Molecular Sequence Data; Mutation; Mutation, Missense | 1999 |
98 other study(ies) available for acetylglucosamine and Disease Models, Animal
Article | Year |
---|---|
O-GlcNAcylation enhances CPS1 catalytic efficiency for ammonia and promotes ureagenesis.
Topics: Acetylglucosamine; Ammonia; Animals; Biocatalysis; Carbamoyl-Phosphate Synthase (Ammonia); Disease Models, Animal; Glycosylation; Humans; Hyperammonemia; Mammals; Mice; N-Acetylglucosaminyltransferases; Propionic Acidemia; Protein Processing, Post-Translational; Urea; Uridine Diphosphate | 2022 |
Sustained Increases in Cardiomyocyte Protein
Topics: Acetylglucosamine; Animals; Cardiomegaly; Cardiovascular Diseases; Disease Models, Animal; Glycosylation; Mice; Mitochondria; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational | 2023 |
O-GlcNAcylation of RAF1 increases its stabilization and induces the renal fibrosis.
Topics: Acetylglucosamine; Acylation; Animals; Cell Line; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Kidney Diseases; Male; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Signal Transduction; Ubiquitination; Ureteral Obstruction | 2020 |
N-Acetylglucosamine is the most effective glucosamine derivative for the treatment of membranous nephropathy in rats.
Topics: Acetylglucosamine; Administration, Oral; Animals; Disease Models, Animal; Doxorubicin; Glomerulonephritis, Membranous; Injections, Intramuscular; Male; Rats | 2019 |
O-GlcNAc stimulation: A new metabolic approach to treat septic shock.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Fluid Therapy; Humans; Lipopolysaccharides; Male; Protein Processing, Post-Translational; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Shock, Septic | 2019 |
Paracoccin: Purification and Validation of Its Lectin and Enzymatic Properties.
Topics: Acetylglucosamine; Animals; Chitinases; Disease Models, Animal; Fungal Proteins; Lectins; Mice; Paracoccidioides; Paracoccidioidomycosis; Protein Binding; Recombinant Proteins; Virulence Factors | 2020 |
Hyper-O-GlcNAcylation impairs insulin response against reperfusion-induced myocardial injury and arrhythmias in obesity.
Topics: Acetylglucosamine; Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Cell Hypoxia; Cell Line; Diazooxonorleucine; Disease Models, Animal; Glycosylation; Humans; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Myocardial Reperfusion Injury; Myocardium; Obesity; Protein Processing, Post-Translational; Rats | 2021 |
Reversibility of motor dysfunction in the rat model of NGLY1 deficiency.
Topics: Acetylglucosamine; Animals; Congenital Disorders of Glycosylation; Disease Models, Animal; Genetic Therapy; Genetic Vectors; Gliosis; Humans; Inflammation; Injections, Intraventricular; Motor Activity; Neurons; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Rats; Rats, Transgenic; Transgenes | 2021 |
Spindle pole cohesion requires glycosylation-mediated localization of NuMA.
Topics: Acetylglucosamine; Animals; Antigens, Nuclear; Blood Proteins; Cell Cycle Proteins; Cell Line; Disease Models, Animal; Epithelial Cells; Galectin 3; Galectins; Glycosylation; Humans; Interphase; Metaphase; Mice; Mice, Knockout; Nuclear Matrix-Associated Proteins; Protein Binding; Protein Processing, Post-Translational; Renal Insufficiency, Chronic; Spindle Poles | 2017 |
The NAG Sensor NagC Regulates LEE Gene Expression and Contributes to Gut Colonization by
Topics: Acetylglucosamine; Animals; Bacterial Adhesion; Bacteroides thetaiotaomicron; Cell Line; Disease Models, Animal; Enterohemorrhagic Escherichia coli; Epithelial Cells; Escherichia coli O157; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; HCT116 Cells; HeLa Cells; Humans; Intestines; Mice; Mice, Inbred BALB C; Mutation; N-Acetylneuraminic Acid; Operon; Phosphoproteins; Repressor Proteins | 2017 |
XBP1 (X-Box-Binding Protein-1)-Dependent O-GlcNAcylation Is Neuroprotective in Ischemic Stroke in Young Mice and Its Impairment in Aged Mice Is Rescued by Thiamet-G.
Topics: Acetylglucosamine; Age Factors; Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotection; Protein Folding; Protein Serine-Threonine Kinases; Pyrans; Stroke; Thiazoles; Unfolded Protein Response; X-Box Binding Protein 1 | 2017 |
Ketogenic diet leads to O-GlcNAc modification in the BTBR
Topics: Acetylglucosamine; Animals; Autistic Disorder; Diet, Ketogenic; Disease Models, Animal; Mice; Mice, Transgenic; Nerve Tissue Proteins; Prefrontal Cortex; Protein Processing, Post-Translational | 2017 |
Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.
Topics: Acetylglucosamine; Animals; Apoptosis; Blood Glucose; Diabetes Complications; Disease Models, Animal; Endoplasmic Reticulum Stress; Enzyme Activation; Female; Glucose; Glycosylation; Maternal Exposure; Metabolic Networks and Pathways; Mice; N-Acetylglucosaminyltransferases; Neural Tube Defects; Pregnancy; Protein Processing, Post-Translational; Reactive Oxygen Species | 2017 |
Dynamic Glycosylation Governs the Vertebrate COPII Protein Trafficking Pathway.
Topics: Acetylglucosamine; Acylation; Animals; Cell Line; Collagen; COP-Coated Vesicles; Craniofacial Abnormalities; Disease Models, Animal; Glycosylation; Humans; Organelles; Protein Conformation; Protein Processing, Post-Translational; Protein Transport; Vertebrates; Vesicular Transport Proteins; Zebrafish | 2018 |
Transcriptome and functional analysis in a Drosophila model of NGLY1 deficiency provides insight into therapeutic approaches.
Topics: Acetylglucosamine; Animals; Congenital Disorders of Glycosylation; Developmental Disabilities; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Endoplasmic Reticulum; Endoplasmic Reticulum-Associated Degradation; Glycosylation; Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase; Proteasome Endopeptidase Complex; Seizures; Sequence Analysis, RNA; Transcriptome | 2018 |
Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A
Topics: Acetylglucosamine; Animals; Antigens, Bacterial; Blood Bactericidal Activity; Cell Wall; Disease Models, Animal; Gene Deletion; Humans; Mice; Polysaccharides, Bacterial; Streptococcal Infections; Streptococcus pyogenes; Survival Analysis; Virulence; Virulence Factors | 2018 |
2-(4-Methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-D-pyranoside, an analog of salidroside, contributes to neuroprotection in cerebral ischemic injury in vitro and in vivo.
Topics: Acetylglucosamine; Animals; Apoptosis; Brain; Brain Ischemia; Capillary Permeability; Cell Hypoxia; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose; Male; Neurons; Neuroprotective Agents; Primary Cell Culture; Random Allocation; Rats, Sprague-Dawley; Time Factors | 2018 |
O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
Topics: Acetylglucosamine; Animals; Anti-Inflammatory Agents; Carotid Artery Injuries; Cell Proliferation; Cells, Cultured; Cytokines; Disease Models, Animal; DNA-Binding Proteins; Glucosamine; Glycosylation; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; NF-kappa B; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor alpha-Induced Protein 3 | 2018 |
Antibodies to Conserved Surface Polysaccharides Protect Mice Against Bacterial Conjunctivitis.
Topics: Acetylglucosamine; Animals; Antibodies, Monoclonal; Bacterial Capsules; Conjunctivitis, Bacterial; Disease Models, Animal; Eye Infections, Bacterial; Female; Immunoglobulin G; Injections, Intraperitoneal; Mice; Mice, Inbred A; Mice, Inbred C57BL; Pneumococcal Infections; Polysaccharides, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae | 2018 |
O-GlcNAcylation of FoxO1 mediates nucleoside diphosphate kinase B deficiency induced endothelial damage.
Topics: Acetylglucosamine; Angiopoietin-2; Animals; Cell Nucleus; Diabetic Retinopathy; Disease Models, Animal; Endothelium, Vascular; Forkhead Box Protein O1; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Knockout; NM23 Nucleoside Diphosphate Kinases; Primary Cell Culture; Retina; Retinal Vessels; RNA, Small Interfering; Up-Regulation | 2018 |
Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease.
Topics: Acetylglucosamine; Alzheimer Disease; Animals; beta-N-Acetylhexosaminidases; Brain; Disease Models, Animal; Female; Humans; Insulin Receptor Substrate Proteins; Male; Mice; Mice, Transgenic; N-Acetylglucosaminyltransferases; Phosphorylation; Proteins; Proteomics; Proto-Oncogene Proteins c-akt | 2018 |
Dietary Natural
Topics: Acetylglucosamine; Administration, Oral; Alkaline Phosphatase; Animals; Calcium; Cell Line; Dietary Supplements; Disease Models, Animal; Female; Femur; Humans; Mice; Osteoblasts; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Rats; Rats, Sprague-Dawley; Tibia; Up-Regulation | 2018 |
2-(4-Methoxyphenyl)ethyl-2-Acetamido-2-deoxy-β-d-pyranoside (A Salidroside Analog) Confers Neuroprotection with a Wide Therapeutic Window by Regulating Local Glucose Metabolism in a Rat Model of Cerebral Ischemic Injury.
Topics: Acetylglucosamine; Animals; Apoptosis; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Glucose; Male; Neurons; Neuroprotective Agents; Rats, Sprague-Dawley; Stroke | 2018 |
Deficient O-GlcNAc Glycosylation Impairs Regulatory T Cell Differentiation and Notch Signaling in Autoimmune Hepatitis.
Topics: Acetylglucosamine; Animals; Cell Differentiation; Concanavalin A; Disease Models, Animal; Gene Knockout Techniques; Glycosylation; Hepatitis, Autoimmune; Liver; Lymphocyte Activation; N-Acetylglucosaminyltransferases; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Notch; Signal Transduction; T-Lymphocytes, Regulatory | 2018 |
Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Isolated Heart Preparation; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats, Zucker | 2019 |
Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes.
Topics: Acetylgalactosamine; Acetylglucosamine; Adoptive Transfer; Animals; Antigen Presentation; Autoantigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Immune Tolerance; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Spleen; T-Lymphocytes | 2019 |
Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation.
Topics: Acetylcholine; Acetylglucosamine; Adenocarcinoma; Animals; Cell Differentiation; Cell Line, Tumor; Colitis; Colon; Colorectal Neoplasms; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Female; Gastrointestinal Diseases; Gene Expression Regulation, Neoplastic; Guanylate Cyclase; Humans; Hyperalgesia; Intestinal Mucosa; Male; Mast Cells; Morphine; Multidrug Resistance-Associated Proteins; Natriuretic Peptides; Organic Anion Transporters, Sodium-Independent; Peroxidase; Rats; Rats, Sprague-Dawley; Rats, Wistar; Restraint, Physical; RNA, Messenger; Signal Transduction; Trinitrobenzenesulfonic Acid; Visceral Pain | 2013 |
Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A/HDAC1/2 complex in the heart.
Topics: Acetylglucosamine; Animals; Blood Glucose; Cardiomegaly; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Exercise Therapy; Gene Expression Regulation; Glycosylation; Histone Deacetylase 1; Histone Deacetylase 2; Mice, Inbred C57BL; Myocardium; N-Acetylglucosaminyltransferases; Obesity; Protein Processing, Post-Translational; Repressor Proteins; RNA, Messenger; Running; Sedentary Behavior; Sin3 Histone Deacetylase and Corepressor Complex; Time Factors | 2013 |
Targeting AMCase reduces esophageal eosinophilic inflammation and remodeling in a mouse model of egg induced eosinophilic esophagitis.
Topics: Acetylglucosamine; Allergens; Animals; Cells, Cultured; Chemokine CCL11; Chitinases; Disease Models, Animal; Eggs; Enzyme Inhibitors; Eosinophilic Esophagitis; Esophagus; Female; Fibrosis; Humans; Hyperplasia; Hypersensitivity, Immediate; Inflammation Mediators; Mice, Inbred BALB C; Molecular Targeted Therapy; Ovalbumin; Trisaccharides | 2014 |
Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy.
Topics: Acetylglucosamine; Animals; CA1 Region, Hippocampal; CA3 Region, Hippocampal; Disease Models, Animal; Female; Glycosylation; Male; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Phosphorylation; Pyrans; tau Proteins; Tauopathies; Thiazoles | 2014 |
Collagen-induced arthritis: severity and immune response attenuation using multivalent N-acetyl glucosamine.
Topics: Acetylglucosamine; Animals; Antigen-Presenting Cells; Arthritis, Experimental; Arthritis, Rheumatoid; B-Lymphocytes; Cell Differentiation; Cells, Cultured; Cytokines; Disease Models, Animal; Female; Humans; Killer Cells, Natural; Male; Mice; Mice, Inbred DBA; NK Cell Lectin-Like Receptor Subfamily K; Synovial Membrane; T-Lymphocytes | 2014 |
Identification of O-GlcNAc modification targets in mouse retinal pericytes: implication of p53 in pathogenesis of diabetic retinopathy.
Topics: Acetylglucosamine; Alloxan; Animals; Apoptosis; Diabetic Retinopathy; Disease Models, Animal; Endothelial Cells; Glucose; Glycosylation; Hyperglycemia; Mice; Pericytes; Retina; Tumor Suppressor Protein p53 | 2014 |
Pericyte protection by edaravone after tissue plasminogen activator treatment in rat cerebral ischemia.
Topics: Acetylglucosamine; Animals; Antipyrine; Astrocytes; Brain Ischemia; Cell Proliferation; Disease Models, Animal; Edaravone; Free Radical Scavengers; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Male; Pericytes; Quinolines; Rats; Rats, Wistar; Receptor, Platelet-Derived Growth Factor beta; Reperfusion; Time Factors; Tissue Plasminogen Activator | 2014 |
Anti-tumor properties of orally administered glucosamine and N-acetyl-D-glucosamine oligomers in a mouse model.
Topics: Acetylglucosamine; Administration, Oral; Animals; Antineoplastic Agents; Apoptosis; Colon; Colonic Neoplasms; Cytokines; Disease Models, Animal; Female; Glucosamine; Immunity, Innate; Interferon-gamma; Mice; Mice, Inbred BALB C | 2014 |
Neurovascular protection by telmisartan via reducing neuroinflammation in stroke-resistant spontaneously hypertensive rat brain after ischemic stroke.
Topics: Acetylglucosamine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Carrier Proteins; Cerebral Cortex; Collagen Type IV; Disease Models, Animal; Encephalitis; Glial Fibrillary Acidic Protein; Hypertension; Infarction, Middle Cerebral Artery; Inflammasomes; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Inbred SHR; Telmisartan; Time Factors | 2015 |
The mitochondrial protein Mcu1 plays important roles in carbon source utilization, filamentation, and virulence in Candida albicans.
Topics: Acetylglucosamine; Amino Acids; Animals; Candida albicans; Candidemia; Carbon; Disease Models, Animal; Fungal Proteins; Gene Deletion; Hyphae; Mice; Mitochondrial Proteins; Multigene Family; Virulence | 2015 |
A nitric oxide-donor furoxan moiety improves the efficacy of edaravone against early renal dysfunction and injury evoked by ischemia/reperfusion.
Topics: Acetylglucosamine; Acute-Phase Proteins; Animals; Antipyrine; Creatinine; Disease Models, Animal; Edaravone; Free Radical Scavengers; Ischemia; Kidney; Lipid Peroxidation; Lipocalin-2; Lipocalins; Male; Malondialdehyde; Nitric Oxide Donors; Oxadiazoles; Oxidative Stress; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reperfusion Injury; Urea | 2015 |
In vivo role of Candida albicans β-hexosaminidase (HEX1) in carbon scavenging.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Candida albicans; Candidiasis; Carbon; Disease Models, Animal; Gas Chromatography-Mass Spectrometry; Hyaluronic Acid; Mice, Inbred BALB C; Virulence; Virulence Factors | 2015 |
Mitochondrial ATP synthase activity is impaired by suppressed O-GlcNAcylation in Alzheimer's disease.
Topics: Acetylglucosamine; Adenosine Triphosphate; Alzheimer Disease; Animals; beta-N-Acetylhexosaminidases; CHO Cells; Cricetulus; Disease Models, Animal; Glycosylation; HeLa Cells; Humans; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Proton-Translocating ATPases; N-Acetylglucosaminyltransferases; Oxidative Phosphorylation Coupling Factors; Protein Processing, Post-Translational | 2015 |
A Novel Murine Candidiasis Model with Severe Colonization in the Stomach Induced by N-acetylglucosamine-treatment and Its Scoring System Based on Local Characteristic Stomach Symptoms.
Topics: Acetylglucosamine; Animals; Candida albicans; Candidiasis; Chlorpromazine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Gastric Mucosa; Immunocompromised Host; Mice, Inbred ICR; Severity of Illness Index; Stomach Diseases | 2015 |
Evidence for an imbalance between tau O-GlcNAcylation and phosphorylation in the hippocampus of a mouse model of Alzheimer's disease.
Topics: Acetylglucosamine; Acylation; Alzheimer Disease; Animals; Brain; Disease Models, Animal; Glycosylation; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Phosphorylation; tau Proteins | 2016 |
Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
Topics: Acetylglucosamine; Animals; Brain; Cerebral Hemorrhage; Combined Modality Therapy; Disease Models, Animal; Fibrinolytic Agents; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats, Sprague-Dawley; Recovery of Function; Stroke; Tissue Plasminogen Activator | 2016 |
Comparison of the chondroprotective effect of a novel hydrogel compound and traditional hyaluronate on rat cartilage in a papain-induced osteoarthritis model.
Topics: Acetylglucosamine; Animals; Cartilage, Articular; Disease Models, Animal; Female; Hyaluronic Acid; Hydrogels; Injections, Intra-Articular; Knee Joint; Osteoarthritis, Knee; Papain; Random Allocation; Rats; Rats, Sprague-Dawley | 2016 |
Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function.
Topics: Acetylglucosamine; Aging; alpha-Synuclein; Animals; Caenorhabditis elegans; Disease Models, Animal; Endosomes; Humans; Lysosomes; Mutation; Polyubiquitin; Protein Aggregates; Transgenes; Ubiquitination | 2016 |
Schwann Cell O-GlcNAc Glycosylation Is Required for Myelin Maintenance and Axon Integrity.
Topics: Acetylglucosamine; Action Potentials; Animals; Autoimmune Diseases of the Nervous System; Axons; Disease Models, Animal; Gene Expression Regulation; Glucose; Glycosylation; Humans; Membrane Proteins; Mice; Mice, Transgenic; Myelin Basic Protein; Myelin Sheath; N-Acetylglucosaminyltransferases; Nerve Tissue Proteins; Neural Conduction; Proteomics; Sciatic Nerve; Tubulin | 2016 |
Characterization of N-Acetylglucosamine Biosynthesis in Pneumocystis species. A New Potential Target for Therapy.
Topics: Acetylglucosamine; Aminoglycosides; Animals; Biosynthetic Pathways; Blotting, Western; Cell Wall; Disease Models, Animal; Fluorescent Antibody Technique; Fungal Proteins; Gas Chromatography-Mass Spectrometry; Genes, Fungal; Lectins; Mice; Molecular Targeted Therapy; Pneumocystis; Pneumonia, Pneumocystis; Rats; RNA, Messenger | 2017 |
The antifungal caspofungin increases fluoroquinolone activity against Staphylococcus aureus biofilms by inhibiting N-acetylglucosamine transferase.
Topics: Acetylglucosamine; Animals; Antifungal Agents; Biofilms; Caspofungin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Echinocandins; Female; Fluoroquinolones; Humans; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; N-Acetylglucosaminyltransferases; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; Biomarkers; Disease Models, Animal; Macrophages; Male; Mice, Inbred C57BL; Microglia; N-Acetylglucosaminyltransferases; Neuroprotective Agents; Pyrans; Signal Transduction; Stroke; Thiazoles; Transcription Factor RelA | 2017 |
Efficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens.
Topics: Acetylglucosamine; Animals; Antilymphocyte Serum; Cornea; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Eye Infections, Fungal; Immunity, Cellular; Immunoglobulin G; Immunotherapy; Keratitis; Mice; Mice, Inbred C57BL | 2016 |
Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling.
Topics: Acetylglucosamine; Acylation; Animals; Animals, Newborn; Cardiotonic Agents; Cells, Cultured; Disease Models, Animal; Glucosamine; Hemodynamics; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Interleukin-6; Lipopolysaccharides; Macrophages; Male; Mice; Myocardial Contraction; Myocytes, Cardiac; N-Acetylglucosaminyltransferases; NF-kappa B; NF-KappaB Inhibitor alpha; Peroxidase; Phosphorylation; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Resuscitation; RNA Interference; RNA, Small Interfering; Shock, Hemorrhagic; Signal Transduction; Transfection; Tumor Necrosis Factor-alpha | 2009 |
Poly-N-acetyl glucosamine nanofibers: a new bioactive material to enhance diabetic wound healing by cell migration and angiogenesis.
Topics: Absorbable Implants; Acetylglucosamine; Animals; Cell Culture Techniques; Cell Movement; Cell Proliferation; Diabetes Complications; Disease Models, Animal; Endothelial Cells; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Skin Ulcer; Tissue Scaffolds; Wound Healing | 2009 |
Fluorinated per-acetylated GalNAc metabolically alters glycan structures on leukocyte PSGL-1 and reduces cell binding to selectins.
Topics: Acetylation; Acetylglucosamine; Animals; Blotting, Western; Bone Marrow Cells; Cell Adhesion; Cell Movement; Chemotaxis, Leukocyte; Disease Models, Animal; Flow Cytometry; Glycosylation; HL-60 Cells; Humans; Leukocytes; Lewis Blood Group Antigens; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Neoplasm Proteins; Peritonitis; Polysaccharides; Protein Binding | 2010 |
Chondroprotective effect of N-acetylglucosamine and hyaluronate in early stages of osteoarthritis--an experimental study in rabbits.
Topics: Acetylglucosamine; Animals; Anterior Cruciate Ligament; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Hyaluronic Acid; Injections, Intra-Articular; Injections, Intramuscular; Knee Joint; Osteoarthritis, Knee; Rabbits; Range of Motion, Articular; Time Factors | 2009 |
Increased O-linked beta-N-acetylglucosamine levels on proteins improves survival, reduces inflammation and organ damage 24 hours after trauma-hemorrhage in rats.
Topics: Acetylglucosamine; Animals; Apoptosis; Blood Gas Analysis; Blood Glucose; Blood Proteins; Cytokines; Disease Models, Animal; Hyperglycemia; Immunoblotting; Inflammation; Male; NF-kappa B; Peroxidase; Phosphorylation; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic | 2010 |
Early initiation of enzyme replacement therapy improves metabolic correction in the brain tissue of aspartylglycosaminuria mice.
Topics: Acetylglucosamine; Age Factors; Animals; Animals, Newborn; Aspartylglucosaminuria; Aspartylglucosylaminase; Biomarkers; Brain; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Replacement Therapy; Humans; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Knockout; NIH 3T3 Cells; Recombinant Proteins; Time Factors; Transfection | 2010 |
Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage.
Topics: Acetylglucosamine; Animals; Antipyrine; Blood-Brain Barrier; Brain Injuries; Cerebral Cortex; Collagen Type IV; Disease Models, Animal; Drug Interactions; Edaravone; Endothelial Cells; Fibrinolytic Agents; Free Radical Scavengers; Gene Expression Regulation; In Vitro Techniques; Lipid Peroxidation; Male; Membrane Proteins; Nerve Tissue Proteins; Occludin; Oxidative Stress; Rats; Rats, Wistar; Tissue Plasminogen Activator | 2010 |
Antitumor activity of N-acetyl-D-glucosamine-substituted glycoconjugates and combined therapy with keyhole limpet hemocyanin in B16F10 mouse melanoma model.
Topics: Acetylglucosamine; Adjuvants, Immunologic; Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Glycoconjugates; Hemocyanins; Humans; Male; Melanoma; Mice; Mice, Inbred C57BL; Skin Neoplasms; Treatment Outcome | 2010 |
Local drug delivery system: inhibition of inflammatory angiogenesis in a murine sponge model by dexamethasone-loaded polyurethane implants.
Topics: Acetylglucosamine; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Biomarkers; Chemistry, Pharmaceutical; Collagen; Dexamethasone; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Implants; Female; Fibrosis; Hemoglobins; Inflammation; Macrophages; Mice; Neovascularization, Pathologic; Neutrophils; Peroxidase; Polyurethanes; Surgical Sponges; Technology, Pharmaceutical; Time Factors | 2011 |
Poly-N-acetyl glucosamine fibers activate bone regeneration in a rabbit femur injury model.
Topics: Acetylglucosamine; Animals; Bone Regeneration; Disease Models, Animal; Femur; Male; Nanofibers; Osteoblasts; Rabbits | 2011 |
Hyperglycemia-induced O-GlcNAcylation and truncation of 4E-BP1 protein in liver of a mouse model of type 1 diabetes.
Topics: Acetylglucosamine; Adaptor Proteins, Signal Transducing; Animals; Blood Glucose; Carrier Proteins; Cell Cycle Proteins; Diabetes Mellitus, Type 1; Disease Models, Animal; Eukaryotic Initiation Factors; Glycosylation; Hyperglycemia; Liver; Mice; Mice, Transgenic; Phlorhizin; Phosphoproteins | 2011 |
A clinical commentary on the article "N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing" : N-acetylglucosamine conjugated nanoparticles: translational o
Topics: Acetylglucosamine; Animals; Cardiovascular Agents; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Carriers; Drug Compounding; Imidazoles; Myocardial Infarction; Myocardium; Nanoparticles; p38 Mitogen-Activated Protein Kinases; Polymers; Protein Kinase Inhibitors; Pyrimidines; Regeneration | 2011 |
N-acetylglucosamine increases symptoms and fungal burden in a murine model of oral candidiasis.
Topics: Acetylglucosamine; Administration, Oral; Animals; Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Disease Models, Animal; Female; Food; Histocytochemistry; Humans; Hyphae; Mice; Mice, Inbred ICR; Microscopy; Tongue; Virulence | 2012 |
Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats.
Topics: Acetylglucosamine; Administration, Oral; Animals; Apoptosis; bcl-2-Associated X Protein; Carnosine; Cytochromes c; Diabetes Mellitus, Experimental; Disease Models, Animal; Glycation End Products, Advanced; Kidney Glomerulus; Oxidative Stress; Podocytes; Rats; Rats, Wistar; Reactive Oxygen Species; Streptozocin | 2011 |
Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation.
Topics: Acetylglucosamine; Adaptor Proteins, Signal Transducing; Alzheimer Disease; Animals; Carbohydrate Conformation; Disease Models, Animal; Enzyme Inhibitors; Female; Humans; Mice; Mice, Transgenic; N-Acetylglucosaminyltransferases; Neurodegenerative Diseases; Neurons; Phosphorylation; Pyrans; tau Proteins; Thiazoles | 2012 |
L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenza A virus infection both in vitro and in vivo.
Topics: Acetylglucosamine; Animals; Cell Line; Complement Pathway, Mannose-Binding Lectin; Disease Models, Animal; Ficolins; Hemagglutinins; Humans; Influenza A virus; Lectins; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neuraminidase; Orthomyxoviridae Infections; Protein Binding; Transgenes; Virus Internalization | 2012 |
Suppressive effects of N-acetyl-D-glucosamine on rheumatoid arthritis mouse models.
Topics: Acetylglucosamine; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Female; Glucosamine; Interleukin-10; Interleukin-2; Interleukin-6; Joints; Mice; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2012 |
Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart.
Topics: Acetylglucosamine; Acylation; Animals; Arterial Pressure; Autophagy; Body Weight; Diabetic Cardiomyopathies; Disease Models, Animal; Hyperglycemia; Male; Myocytes, Cardiac; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction | 2013 |
Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Topics: Acetylglucosamine; Animals; Antibodies, Bacterial; Antibody Specificity; Bacteremia; Chromatography, Gel; Coagulase; Cytotoxicity, Immunologic; Disease Models, Animal; Female; Fibrinogen; Goats; Immobilized Proteins; Immune Sera; Macaca mulatta; Mice; Microscopy, Confocal; Models, Immunological; Opsonin Proteins; Phagocytes; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vaccines, Conjugate | 2012 |
O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases.
Topics: Acetylglucosamine; Alleles; Animals; Caenorhabditis elegans; Disease Models, Animal; Humans; Mutation; Neurodegenerative Diseases; Proteolysis | 2012 |
O-GlcNAc cycling modulates neurodegeneration.
Topics: Acetylglucosamine; Animals; Caenorhabditis elegans; Disease Models, Animal; Humans; Mutation; Neurodegenerative Diseases | 2012 |
Ischemic preconditioning increases myocardial O-GlcNAc glycosylation.
Topics: Acetylglucosamine; Alloxan; Animals; Azaserine; Disease Models, Animal; Glycosylation; Hemodynamics; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; N-Acetylglucosaminyltransferases; Rats; Rats, Wistar; Recovery of Function; Time Factors; Up-Regulation | 2013 |
Comparison of alteration of cell surface carbohydrates of the chinchilla tubotympanum and colonial opacity phenotype of Streptococcus pneumoniae during experimental pneumococcal otitis media with or without an antecedent influenza A virus infection.
Topics: Acetylglucosamine; Animals; Carbohydrate Metabolism; Cell Membrane; Chinchilla; Disease Models, Animal; Ear, Middle; Eustachian Tube; Galactose; Humans; Influenza A virus; Influenza, Human; Lectins; Nasopharynx; Otitis Media; Peanut Agglutinin; Phenotype; Plant Lectins; Pneumococcal Infections; Sialic Acids; Streptococcus pneumoniae; Wheat Germ Agglutinins | 2002 |
Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats.
Topics: Acetylglucosamine; Acetylglucosaminidase; Animals; beta-N-Acetylhexosaminidases; Cornea; Corneal Diseases; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Histone Acetyltransferases; In Situ Hybridization; Male; Multienzyme Complexes; N-Acetylglucosaminyltransferases; Organ Culture Techniques; Rabbits; Rats; Rats, Wistar; RNA Probes; RNA, Messenger | 2003 |
Novel glycosaminoglycan precursors as anti-amyloid agents, part III.
Topics: Acetylglucosamine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Basement Membrane; Brain; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glycosaminoglycans; Golgi Apparatus; Heparan Sulfate Proteoglycans; Hepatocytes; Macrophages; Mice; Molecular Structure; Plaque, Amyloid | 2003 |
Application of the poly-N-acetyl glucosamine-derived rapid deployment hemostat trauma dressing in severe/lethal Swine hemorrhage trauma models.
Topics: Acetylglucosamine; Animals; Aorta, Abdominal; Aprotinin; Bandages; Blood Cell Count; Blood Volume; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Femoral Artery; Fibrinogen; Hemorrhage; Hemostatic Techniques; Hemostatics; Military Medicine; Platelet Count; Survival Rate; Swine; Thrombin; Time Factors; Wounds, Penetrating | 2004 |
Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage.
Topics: Acetylglucosamine; Administration, Topical; Animals; Aprotinin; Body Temperature; Cellulose, Oxidized; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Female; Fibrin Foam; Fibrin Tissue Adhesive; Fibrinogen; Hemophilia B; Hemorrhage; Hemostatic Techniques; Hemostatics; Hypothermia, Induced; Rabbits; Spleen; Swine; Thrombin; Wounds, Penetrating | 2004 |
Randomized double-blind studies of polysaccharide gel compared with glue and other agents for hemostasis of large veins and bleeding canine esophageal or gastric varices.
Topics: Acetylglucosamine; Alcohols; Animals; Chemistry, Pharmaceutical; Disease Models, Animal; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Enbucrilate; Esophageal and Gastric Varices; Esophagoscopy; Gastrointestinal Hemorrhage; Gastroscopy; Gels; Hemostatic Techniques; Hemostatics; Hypertension, Portal; Oleic Acids; Random Allocation; Sclerosing Solutions; Sclerotherapy; Sodium Morrhuate; Wound Healing | 2004 |
Hemostasis in the absence of clotting factors.
Topics: Acetylglucosamine; Administration, Topical; Animals; Aorta, Abdominal; Azepines; Bandages; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelin A Receptor Antagonists; Female; Hemorrhage; Hemostatic Techniques; Hemostatics; Male; Oligopeptides; Rats; Receptor, Endothelin A; Time Factors; Wounds, Penetrating | 2004 |
Novel glycosaminoglycan precursors as antiamyloid agents: Part IV.
Topics: Acetylglucosamine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Basement Membrane; Cell Adhesion; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Glycosaminoglycans; Heparan Sulfate Proteoglycans; Hepatocytes; Macrophages; Mice; Mice, Transgenic; Neuroprotective Agents; Protein Conformation | 2004 |
Specific induction of macrophage inflammatory protein 1-alpha in glial cells of Sandhoff disease model mice associated with accumulation of N-acetylhexosaminyl glycoconjugates.
Topics: Acetylglucosamine; Animals; Astrocytes; beta-N-Acetylhexosaminidases; Brain; Calcium-Binding Proteins; Chemokine CCL3; Chemokine CCL4; Chemokines; Disease Models, Animal; Disease Progression; G(M2) Ganglioside; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glycoconjugates; Hexosaminidase A; Hexosaminidase B; Macrophage Inflammatory Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microfilament Proteins; Microglia; Neuroglia; Protein Subunits; RNA, Messenger; Sandhoff Disease; Up-Regulation | 2005 |
Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in diabetes-associated erectile dysfunction.
Topics: Acetylglucosamine; Animals; Diabetes Complications; Disease Models, Animal; Enzyme Activation; Erectile Dysfunction; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Penile Erection; Penis; Phosphorylation; Phosphoserine; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2005 |
N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats.
Topics: Acetylglucosamine; Acute Disease; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Glucose; Inflammation; Kinetics; Lipopolysaccharides; Male; Osmolar Concentration; Peritoneal Dialysis; Peritonitis; Rats; Rats, Wistar; Uremia | 2006 |
Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.
Topics: Acetylglucosamine; Acetylglucosaminidase; Alleles; Animals; Animals, Genetically Modified; beta-N-Acetylhexosaminidases; Caenorhabditis elegans; Disease Models, Animal; Hexosamines; Histone Acetyltransferases; Insulin; Insulin Resistance; Molecular Sequence Data; Multienzyme Complexes; Mutation; Phosphorylation; Signal Transduction | 2006 |
Heparan sulfate analysis from diabetic rat glomeruli.
Topics: Acetylglucosamine; Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disaccharides; Disease Models, Animal; Heparitin Sulfate; Kidney Glomerulus; Male; Oligosaccharides; Polysaccharide-Lyases; Rats; Rats, Sprague-Dawley; Sulfates | 2007 |
Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide.
Topics: Acetylglucosamine; Animals; Antibodies, Bacterial; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Mice; Polysaccharides, Bacterial; Staphylococcus aureus | 2007 |
Effects of poly-N-acetyl glucosamine (pGlcNAc) patch on wound healing in db/db mouse.
Topics: Acetylglucosamine; Analysis of Variance; Animals; Bandages; Diabetes Mellitus, Experimental; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Skin; Wound Healing | 2008 |
Murine platelets are not regulated by O-linked beta-N-acetylglucosamine.
Topics: Acetylglucosamine; Animals; Blood Glucose; Blood Platelets; Blotting, Western; Diabetes Mellitus, Experimental; Disease Models, Animal; Mice; Mice, Inbred C57BL; Platelet Aggregation | 2008 |
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.
Topics: Acetylglucosamine; Animals; Anti-Inflammatory Agents; Carotid Arteries; Carotid Artery Injuries; Disease Models, Animal; Female; Glucosamine; Glycosylation; Inflammation Mediators; Monocytes; Neutrophil Infiltration; Ovariectomy; Oximes; Phenylcarbamates; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |
Prospects for enzyme replacement for lysosomal storage diseases.
Topics: Acetylglucosamine; Animals; Cell Membrane; Disease Models, Animal; Enzyme Therapy; Enzymes; Fibroblasts; Humans; Mannans; Mannosephosphates; Metabolism, Inborn Errors; Mononuclear Phagocyte System; Pinocytosis; Rats | 1981 |
A mouse model for the human lysosomal disease aspartylglycosaminuria.
Topics: Acetylglucosamine; Age Factors; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Central Nervous System; Disease Models, Animal; Female; Humans; Lysosomal Storage Diseases; Lysosomes; Male; Mice; Mice, Knockout; Psychomotor Performance; RNA, Messenger; Stem Cells; Urinary Bladder | 1996 |
Post-partum flare in MRL-lpr/lpr mice is associated with a parallel increase of N-acetylglucosamine on serum IgG.
Topics: Acetylglucosamine; Animals; Ankle Joint; Arthritis, Rheumatoid; Disease Models, Animal; Female; Galactose; Glycosylation; Hindlimb; Immunoglobulin G; Male; Mice; Mice, Inbred MRL lpr; Postpartum Period; Pregnancy | 1997 |
Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients.
Topics: Acetylglucosamine; Animals; Aspartylglucosaminuria; Aspartylglucosylaminase; Brain; Disease Models, Animal; Disease Progression; Gene Targeting; Genes, Recessive; Humans; Intellectual Disability; Liver; Lysosomal Storage Diseases; Magnetic Resonance Imaging; Maze Learning; Mice; Mice, Knockout; Microscopy, Electron; Phenotype | 1998 |
Mannan decelerates the clearance of human red blood cells in SCID mouse.
Topics: Acetylglucosamine; Animals; Candida; Chimera; Chitin; Disease Models, Animal; Erythrocyte Transfusion; Erythrocytes; Female; Glucose; Humans; Lactoferrin; Macrophages; Malaria, Falciparum; Male; Mannans; Mice; Mice, SCID; Phagocytosis; Receptors, Mitogen; Yeasts | 1998 |
Phenotypic characterization of mice with targeted disruption of glycosylasparaginase gene: a mouse model for aspartylglycosaminuria.
Topics: Acetylglucosamine; Animals; Aspartylglucosylaminase; Disease Models, Animal; Gene Targeting; Lysosomal Storage Diseases; Mice; Phenotype | 1998 |
Endoscopic injection of bleeding esophageal varices with a poly-N-acetyl glucosamine gel formulation in the canine portal hypertension model.
Topics: Acetylglucosamine; Animals; Disease Models, Animal; Dogs; Endosonography; Enzyme-Linked Immunosorbent Assay; Esophageal and Gastric Varices; Esophagoscopy; Female; Fluoroscopy; Gastrointestinal Hemorrhage; Gels; Homeostasis; Hypertension, Portal; Injections, Intralesional; Male; Treatment Outcome | 1999 |
A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent.
Topics: Acetylation; Acetylglucosamine; Administration, Topical; Adult; Animals; Digestive System Surgical Procedures; Disease Models, Animal; Female; Gastrointestinal Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Intestine, Small; Male; Pilot Projects; Polysaccharides; Postoperative Hemorrhage; Spleen; Swine | 1999 |
N-acetylglucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID).
Topics: Acetylglucosamine; Animals; Disease Models, Animal; Electrophoresis, Cellulose Acetate; Fibroblasts; Glycosaminoglycans; Goats; Male; Mucopolysaccharidosis III; Sulfatases; Sulfates | 1992 |
Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis.
Topics: Acetylglucosamine; Animals; Antigen-Antibody Complex; Arthritis, Rheumatoid; Carbohydrate Sequence; Disease Models, Animal; Galactose; Glycosylation; Immunoglobulin G; Lectins; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Molecular Sequence Data; Oligosaccharides; Protein Processing, Post-Translational | 1990 |